MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call
MacroGenics (MGNX) has scheduled its Q3 2024 financial results conference call for Tuesday, November 5, 2024, after market close. The company will host a conference call at 4:30 pm ET to discuss financial results and recent corporate progress. Participants can register in advance for telephone access, and a webcast will be available under the Investor Relations section of MacroGenics' website. A replay will be archived for 30 days following the call.
MacroGenics (MGNX) ha programmato la chiamata per i risultati finanziari del Q3 2024 per martedì 5 novembre 2024, dopo la chiusura del mercato. L'azienda ospiterà una chiamata alle 16:30 ET per discutere i risultati finanziari e i recenti progressi aziendali. I partecipanti possono registrarsi in anticipo per l'accesso telefonico, e un webcast sarà disponibile nella sezione Relazioni con gli Investitori del sito web di MacroGenics. Una registrazione sarà archiviata per 30 giorni dopo la chiamata.
MacroGenics (MGNX) ha programado su llamada de conferencia sobre los resultados financieros del Q3 2024 para el martes 5 de noviembre de 2024, después del cierre del mercado. La compañía llevará a cabo una llamada a las 4:30 p. m. ET para discutir los resultados financieros y los recientes avances corporativos. Los participantes pueden registrarse por adelantado para el acceso telefónico, y una transmisión estará disponible en la sección de Relaciones con Inversores del sitio web de MacroGenics. Se archivará una repetición durante 30 días después de la llamada.
MacroGenics (MGNX)는 2024년 3분기 재무 결과에 대한 컨퍼런스 콜을 2024년 11월 5일 화요일 시장 마감 후에 예정하고 있습니다. 회사는 동부 표준시로 오후 4시 30분에 재무 결과 및 최근 기업 발전에 대해 논의하기 위해 컨퍼런스 콜을 개최합니다. 참가자는 전화 접근을 위해 사전 등록할 수 있으며, MacroGenics 웹사이트의 투자자 관계 섹션에서 웹캐스트를 이용할 수 있습니다. 콜 후 30일 동안 재생 기록이 보관됩니다.
MacroGenics (MGNX) a programmé sa conférence téléphonique sur les résultats financiers du T3 2024 pour le mardi 5 novembre 2024, après la clôture du marché. L'entreprise animera une conférence téléphonique à 16h30 HE pour discuter des résultats financiers et des récents progrès de l'entreprise. Les participants peuvent s'inscrire à l'avance pour accéder par téléphone, et un webinaire sera disponible dans la section Relations avec les investisseurs du site Web de MacroGenics. Un enregistrement sera archivé pendant 30 jours après l'appel.
MacroGenics (MGNX) hat seine Konferenzschaltung zu den Q3 2024 Finanzresultaten für Dienstag, den 5. November 2024, nach Handelsende geplant. Das Unternehmen wird um 16:30 Uhr ET eine Konferenzschaltung abhalten, um die Finanzresultate und den jüngsten Unternehmensfortschritt zu besprechen. Teilnehmer können sich im Voraus für den telefonischen Zugriff registrieren, und ein Webcast wird im Bereich Investor Relations der Website von MacroGenics verfügbar sein. Eine Wiederholung wird 30 Tage nach dem Anruf archiviert.
- None.
- None.
ROCKVILLE, MD, Oct. 29, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today announced that the Company will release its financial results for the third quarter of 2024 after the market closes on Tuesday, November 5, 2024. MacroGenics will host a conference call to discuss the financial results and recent corporate progress on Tuesday, November 5, 2024, at 4:30 pm ET.
Conference Call Information
To participate via telephone, please register in advance via this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. The listen-only webcast of the conference call can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at http://ir.macrogenics.com/events.cfm. A recorded replay of the webcast will be available shortly after the conclusion of the call and archived on the Company's website for 30 days following the call.
About MacroGenics, Inc.
MacroGenics (the Company) is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. The combination of MacroGenics' technology platforms and protein engineering expertise has allowed the Company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. For more information, please see the Company's website at www.macrogenics.com. MacroGenics and the MacroGenics logo are trademarks or registered trademarks of MacroGenics, Inc.
###
FAQ
When will MacroGenics (MGNX) release Q3 2024 earnings?
What time is MacroGenics (MGNX) Q3 2024 earnings call?
How can I access MacroGenics (MGNX) Q3 2024 earnings call?
How long will MacroGenics (MGNX) Q3 2024 earnings call replay be available?
